Global burden of multiple myeloma in adolescents and young adults, 1990-2021

1. Global MM incidence in AYA increased 60% (1990-2021), with males experiencing 43% higher rates and widening health inequalities. 2. Middle SDI regions show the steepest burden increases (prevalence EAPC: 3.50%), requiring enhanced diagnostic capacity and treatment access. Multiple myeloma (MM) research has predominantly focused on elderly populations, leaving the burden among adolescents and young adults (AYA, aged 15-39 years) incompletely characterized. This study utilized Global Burden of Disease Study 2021 (GBD 2021) data to comprehensively assess global trends in MM burden among AYA from 1990 to 2021. We analyzed age-standardized incidence, mortality, and disability-adjusted life years (DALY) rates across genders, regions, and sociodemographic index (SDI) levels. Temporal trends were quantified using estimated annual percentage change (EAPC). Decomposition analysis identified drivers of burden changes, while inequality was assessed using slope index of inequality (SII) and concentration index. Future projections were generated using the Nordpred model. From 1990 to 2021, global age-standardized incidence rates increased 60% (from 0.05 to 0.08 per 100,000), with incident cases more than doubling from 1,013 to 2,537. Males experienced 43% higher incidence than females. Middle SDI regions showed the most pronounced prevalence increases (EAPC: 3.50%, 95% CI: 3.31-3.69), while high SDI regions exhibited declining mortality (EAPC: -0.15%, 95% CI: -0.25 to -0.06) and DALY rates (EAPC: -0.08%, 95% CI: -0.17 to 0.01). Epidemiological changes drove 47.93% of global DALY increases. Health inequalities worsened for males (SII increased from 2 to 3) but improved for females (SII decreased from 2 to 1). Projections indicate continued burden increases through 2040, particularly among males. MM burden among AYA increased substantially with marked heterogeneity across genders and SDI regions, necessitating targeted prevention strategies and enhanced care access, particularly in middle SDI regions and male populations.

Authors

Institutions

Publication Details

Journal
Blood Global Hematology
Published
2026-01-27
DOI
https://doi.org/10.1016/j.bglo.2026.100063
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global burden of multiple myeloma in adolescents and young adults, 1990-2021

Guoxin Huang, Hongkun Wu, Lin Zhou, Jiafeng zhang et al.
Blood Global Hematology
Multiple Myeloma Research and Treatments
article

Global burden of multiple myeloma in adolescents and young adults, 1990-2021

Guoxin Huang, Hongkun Wu, Lin Zhou, Jiafeng zhang, Chang Liu, Ting Zhang
article en

Abstract

1. Global MM incidence in AYA increased 60% (1990-2021), with males experiencing 43% higher rates and widening health inequalities. 2. Middle SDI regions show the steepest burden increases (prevalence EAPC: 3.50%), requiring enhanced diagnostic capacity and treatment access. Multiple myeloma (MM) research has predominantly focused on elderly populations, leaving the burden among adolescents and young adults (AYA, aged 15-39 years) incompletely characterized. This study utilized Global Burden of Disease Study 2021 (GBD 2021) data to comprehensively assess global trends in MM burden among AYA from 1990 to 2021. We analyzed age-standardized incidence, mortality, and disability-adjusted life years (DALY) rates across genders, regions, and sociodemographic index (SDI) levels. Temporal trends were quantified using estimated annual percentage change (EAPC). Decomposition analysis identified drivers of burden changes, while inequality was assessed using slope index of inequality (SII) and concentration index. Future projections were generated using the Nordpred model. From 1990 to 2021, global age-standardized incidence rates increased 60% (from 0.05 to 0.08 per 100,000), with incident cases more than doubling from 1,013 to 2,537. Males experienced 43% higher incidence than females. Middle SDI regions showed the most pronounced prevalence increases (EAPC: 3.50%, 95% CI: 3.31-3.69), while high SDI regions exhibited declining mortality (EAPC: -0.15%, 95% CI: -0.25 to -0.06) and DALY rates (EAPC: -0.08%, 95% CI: -0.17 to 0.01). Epidemiological changes drove 47.93% of global DALY increases. Health inequalities worsened for males (SII increased from 2 to 3) but improved for females (SII decreased from 2 to 1). Projections indicate continued burden increases through 2040, particularly among males. MM burden among AYA increased substantially with marked heterogeneity across genders and SDI regions, necessitating targeted prevention strategies and enhanced care access, particularly in middle SDI regions and male populations.

Blood Global HematologyVol. 2(1)
Shanghai Changzheng Hospital (CN), Hubei University of Arts and Science (CN), Xiang Yang No.1 People's Hospital (CN), Nanjing Medical University (CN)
Good health and well-being
Openalex Percentile: Top 79%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.